| Name | α-dihydrolycorine |
|---|---|
| Synonyms |
(1S,2S,3aR,12bS,12cR)-2,3,3a,4,5,7,12b,12c-Octahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol
Dihydrolycorine 1H-[1,3]Dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, 2,3,3a,4,5,7,12b,12c-octahydro-, (1S,2S,3aR,12bS,12cR)- ihydrolycorine |
| Description | Dihydrolycorine is isolated from Lycoris radiate Herb with antihypertensive and neuroprotective activities[1]. Dihydrolycorine is an inhibitor of protein synthesis in eukarytic cells by inhibiting the peptide bone formation step[2]. |
|---|---|
| Related Catalog | |
| Target |
Protein synthesis[2] |
| In Vivo | Dihydrolycorine reduces infarct size, cerebral edema, and myeloperoxidase activity in a rat model of focal cerebral ischemia-reperfusion injury when administered following reperfusion[1]. Dihydrolycorine inhibits methoxamine-induced contraction of isolated rabbit aortic rings and rat anococcygeus muscle with pA2 values of 5.93 and 6.35, respectively[3]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 460.5±45.0 °C at 760 mmHg |
| Melting Point | 247℃ |
| Molecular Formula | C16H19NO4 |
| Molecular Weight | 289.326 |
| Flash Point | 232.3±28.7 °C |
| Exact Mass | 289.131409 |
| PSA | 62.16000 |
| LogP | 0.85 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.701 |